Labopharm Reports Results for Third Quarter F...(September 30 December 31 ...),Health

2007 2006

(Thousands of Canadian dollars) $ $

-------------------------------------------------------------------------

ASSETS

Current

Cash and cash equivalents 9,069 13,722

Available-for-sale marketable securities 59,370 85,747

Accounts receivable 5,005 4,002

Research and development tax credits receivable 1,264 1,869

Income taxes receivable - 939

Inventories 3,258 5,287

Prepaid expenses and other assets 1,705 1,384

-------------------------------------------------------------------------

Total current assets 79,671 112,950

-------------------------------------------------------------------------

Restricted long-term investments 1,273 1,280

Long-term investment 4,867 -

Property, plant and equipment, net 10,845 10,909

Intangible assets 3,484 3,205

Deferred financing costs - 156

Future income tax asset 198 134

-------------------------------------------------------------------------

100,338 128,634

-------------------------------------------------------------------------

-------------------------------------------------------------------------

LIABILITIES AND SHAREHOLDERS' EQUITY

Current

Accounts payable and accrued liabilities
'/>"/>